Glenmark Pharmaceuticals Sees Surge in Active Call Options with 7,024 Contracts at Rs 2100 Strike

Glenmark Pharmaceuticals Ltd. has emerged as one of the most active stocks today, particularly in the options market. The company, operating within the Pharmaceuticals & Biotechnology sector, has seen significant trading activity in call options set to expire on July 31, 2025.
Notably, the call option with a strike price of Rs 2100 led the activity with 7,024 contracts traded, generating a turnover of approximately Rs 4,627.86 lakhs and an open interest of 1,687 contracts. Following closely, the Rs 2000 strike price option recorded 5,051 contracts traded and a turnover of Rs 4,348.88 lakhs, while the Rs 2300 strike price option saw 5,340 contracts traded with a turnover of Rs 1,648.99 lakhs and an open interest of 1,185 contracts.

Today, Glenmark's stock reached a new 52-week and all-time high of Rs 2,094.4, reflecting a 10% gain at the opening. The stock has outperformed its sector by 9.27% and has shown a consecutive gain over the last two days, yielding a total return of 15.15%. Additionally, Glenmark is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a strong upward trend.

With a market capitalization of Rs 53,763 crore, Glenmark Pharmaceuticals continues to demonstrate robust performance metrics and increased investor participation, highlighted by a delivery volume of 9.28 lakhs on July 10, which is 72.44% higher than the 5-day average. Overall, the stock's activity today underscores its significant position in the market.